Jonathan L Halperin Selected Research

Vitamin K

5/2022	Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
5/2022	Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.
5/2022	Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
1/2022	Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
10/2021	Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial.
8/2021	Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.
3/2021	Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry.
6/2020	Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
6/2020	Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA-AF registry.
11/2019	Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan L Halperin Research Topics

Disease

121	Atrial Fibrillation 09/2022 - 05/2003
114	Stroke (Strokes) 09/2022 - 05/2003
73	Hemorrhage 11/2022 - 05/2003
56	Embolism (Embolus) 10/2022 - 03/2004
19	Heart Failure 06/2018 - 09/2004
14	Thromboembolism 12/2021 - 09/2003
13	Myocardial Infarction 05/2022 - 11/2006
11	Transient Ischemic Attack 06/2018 - 09/2004
11	Ischemic Stroke 01/2018 - 09/2004
10	Hypertension (High Blood Pressure) 01/2018 - 09/2004
9	Venous Thromboembolism 11/2022 - 08/2009
9	Atherosclerosis 01/2021 - 11/2010
8	Thrombosis (Thrombus) 12/2018 - 09/2004
7	Peripheral Arterial Disease 09/2022 - 03/2006
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 09/2011
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018 - 11/2006
5	Vascular Diseases (Vascular Disease) 01/2018 - 06/2004
4	COVID-19 12/2021 - 01/2020
3	Diabetes Mellitus 01/2018 - 09/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2017 - 11/2005
3	Hemorrhagic Stroke 02/2017 - 07/2013
3	Cardiac Arrhythmias (Arrythmia) 07/2015 - 12/2011
2	Sepsis (Septicemia) 12/2021 - 12/2021
2	Renal Insufficiency (Renal Failure) 09/2018 - 08/2014
2	Carotid Artery Diseases 01/2018 - 01/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2016 - 03/2014
2	Mitral Valve Stenosis (Mitral Stenosis) 01/2016 - 12/2014
2	Anemia 12/2015 - 03/2014
2	Cerebral Hemorrhage 10/2015 - 01/2011
2	Acute Coronary Syndrome 11/2013 - 11/2008
2	Left Ventricular Dysfunction 01/2011 - 11/2006
2	Embolic Stroke 08/2007 - 05/2003
1	Fever (Fevers) 11/2022
1	Critical Illness (Critically Ill) 12/2021
1	Tachycardia (Tachyarrhythmias) 11/2020
1	Neoplasms (Cancer) 01/2019
1	Ischemia 01/2018
1	Overweight 01/2017
1	Body Weight (Weight, Body) 01/2017
1	ST Elevation Myocardial Infarction 05/2016
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 03/2016

Drug/Important Bio-Agent (IBA)

77	Warfarin (Coumadin)FDA LinkGeneric 09/2022 - 05/2003
60	Vitamin K FDA Link 05/2022 - 09/2004
55	RivaroxabanIBA 10/2022 - 09/2011
38	AnticoagulantsIBA 11/2022 - 03/2004
31	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 01/2013
15	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2017 - 05/2003
14	Pharmaceutical PreparationsIBA 10/2022 - 01/2008
12	Dabigatran FDA Link 05/2022 - 03/2011
9	N(4)-oleylcytosine arabinosideIBA 08/2021 - 06/2014
9	ximelagatran (Exanta)IBA 08/2009 - 09/2003
7	CreatinineIBA 01/2022 - 02/2011
6	apixabanIBA 05/2022 - 02/2013
6	AntithrombinsIBA 02/2013 - 09/2003
6	Thrombin FDA Link 01/2011 - 03/2004
4	edoxabanIBA 09/2022 - 11/2013
4	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 08/2008
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 06/2020 - 01/2011
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2019 - 07/2015
4	Dronedarone FDA Link 11/2017 - 12/2011
4	Anti-Arrhythmia AgentsIBA 03/2017 - 02/2011
3	fibrin fragment D (D-dimer)IBA 12/2021 - 09/2018
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2017 - 05/2003
3	Digoxin (Digitek)FDA LinkGeneric 06/2015 - 08/2014
3	Amiodarone (Amiodarona)FDA LinkGeneric 10/2014 - 05/2007
3	Factor Xa InhibitorsIBA 07/2014 - 10/2011
3	Clopidogrel (Plavix)FDA Link 02/2012 - 01/2008
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 12/2021 - 12/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 10/2014
2	Angiotensin Receptor AntagonistsIBA 01/2020 - 10/2014
1	Enoxaparin (Lovenox)FDA LinkGeneric 10/2022
1	Oxygen (Dioxygen)IBA 12/2021
1	Insulin (Novolin)FDA Link 06/2021
1	Troponin IIBA 11/2020
1	Proton Pump InhibitorsIBA 06/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2020
1	DABIIBA 01/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2017
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2017

Therapy/Procedure

70	Therapeutics 11/2022 - 05/2003
11	Percutaneous Coronary Intervention 11/2020 - 11/2008
11	Vascular Surgical Procedures 01/2013 - 03/2006
8	Electric Countershock (Cardioversion) 01/2021 - 09/2004
4	Stents 01/2018 - 02/2008
4	Defibrillators (Defibrillator) 12/2016 - 05/2007
3	Drug Therapy (Chemotherapy) 06/2021 - 12/2015
3	Drug-Eluting Stents 11/2020 - 01/2008
2	Thrombolytic Therapy 11/2017 - 09/2004
2	Polypharmacy 07/2016 - 01/2016
2	Prostheses and Implants (Prosthesis) 01/2016 - 12/2014
2	Cardiac Resynchronization Therapy 07/2015 - 09/2009
2	Catheter Ablation 05/2013 - 11/2012
1	Duration of Therapy 11/2022
1	Patient Readmission 11/2019
1	Heart Transplantation (Grafting, Heart) 12/2018
1	Endarterectomy (Thromboendarterectomy) 01/2018
1	Vascular Closure Devices 01/2018
1	Thrombectomy 03/2017
1	Anesthesia 12/2016